Review



recombinant human vascular endothelial growth factor  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    R&D Systems recombinant human vascular endothelial growth factor
    Recombinant Human Vascular Endothelial Growth Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 275 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+vascular+endothelial+growth+factor+d+vegf+d/Recombinant+Human+VEGF-D+Protein/pm41311054-50-85-92
    Average 95 stars, based on 275 article reviews
    recombinant human vascular endothelial growth factor - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Cardioprotective Actions of TGFβRI Inhibition Through Stimulating Autocrine/Paracrine of Survivin and Inhibiting Wnt in Cardiac Progenitors.
    Article Snippet: PD0325901, CHIR99021, LY294002, and DAPT were purchased from Cayman Chemical Company (Ann Arbor, MI, USA, https://www.caymanchem.com/app/template/ globalBuyersGuide%2CTerritory.vm/territory/vi/countryregionid/vi). .. Recombinant human survivin was purchased from BioVision, Inc. (Milpitas, CA, USA, http://www.biovision.com/survivinhuman-recombinant-4029.html), recombinant Human Pref-1/ DLK-1/FA1, recombinant human Wnt3a, and recombinant human vascular endothelial growth factor-D (VEGF-D) from R&D Systems, Inc. (Minneapolis, MN, USA. https://www.rndsys tems.com/products/proteins). ..



    Similar Products

    recombinant human vascular endothelial growth factor  (R&D Systems)
    95
    R&D Systems recombinant human vascular endothelial growth factor
    Recombinant Human Vascular Endothelial Growth Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+vascular+endothelial+growth+factor+d+vegf+d/Recombinant+Human+VEGF-D+Protein/pm41311054-50-85-92
    Average 95 stars, based on 1 article reviews
    recombinant human vascular endothelial growth factor - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    recombinant human vascular endothelial growth factor a vegf a  (R&D Systems)
    95
    R&D Systems recombinant human vascular endothelial growth factor a vegf a
    Recombinant Human Vascular Endothelial Growth Factor A Vegf A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+vascular+endothelial+growth+factor+d+vegf+d/Recombinant+Human+VEGF-D+Protein/pm38999055-329-0-13
    Average 95 stars, based on 1 article reviews
    recombinant human vascular endothelial growth factor a vegf a - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    1381 vascular endothelial growth factor vegf  (R&D Systems)
    95
    R&D Systems 1381 vascular endothelial growth factor vegf
    Fig. 6 ADAM12 regulates the effect of colon cancer cells on neighboring <t>endothelial</t> cells in vitro. A Experimental setup used to obtain conditioned media (CM) from irradiated or non-irradiated WT and A12−/−SW480 colon cancer cells (CaCe) used to test the effect on tube formation in HUVECs (created with BioRender.com). B Example of tube formation by HUVECs with examples of branches, junctions, and meshes. C–E Quantified branches (C), junctions (D), and meshes (E) formed by HUVECs when exposed to CM from SW480 cells, serum-free media (SFM), or recombinant <t>VEGF,</t> relative to stimulation with recombinant VEGF. One-way ANOVA with correction for multiple comparisons using false discovery rate (FDR) control by Benjamini, Krieger, and Yekutieli method was applied to test for significant differences: *p < 0.05, **p < 0.01, ***p < 0.001.
    1381 Vascular Endothelial Growth Factor Vegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+vascular+endothelial+growth+factor+d+vegf+d/Recombinant+Human+VEGF-D+Protein/pm37495855-127-18-25
    Average 95 stars, based on 1 article reviews
    1381 vascular endothelial growth factor vegf - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    human recombinant vascular endothelial growth factor vegf  (R&D Systems)
    93
    R&D Systems human recombinant vascular endothelial growth factor vegf
    A Experimental setup used to obtain conditioned media (CM) from irradiated or non-irradiated WT and A12 −/− SW480 colon cancer cells (CaCe) used to test the effect on tube formation in HUVECs (created with BioRender.com). B Example of tube formation by HUVECs with examples of branches, junctions, and meshes. C – E Quantified branches ( C ), junctions ( D ), and meshes ( E ) formed by HUVECs when exposed to CM from SW480 cells, serum-free media (SFM), or <t>recombinant</t> <t>VEGF,</t> relative to stimulation with recombinant VEGF. One-way ANOVA with correction for multiple comparisons using false discovery rate (FDR) control by Benjamini, Krieger, and Yekutieli method was applied to test for significant differences: * p < 0.05, ** p < 0.01, *** p < 0.001.
    Human Recombinant Vascular Endothelial Growth Factor Vegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+vascular+endothelial+growth+factor+d+vegf+d/Recombinant+Human+VEGF-D+Protein/pmc10581903-128-11-18
    Average 93 stars, based on 1 article reviews
    human recombinant vascular endothelial growth factor vegf - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 6 ADAM12 regulates the effect of colon cancer cells on neighboring endothelial cells in vitro. A Experimental setup used to obtain conditioned media (CM) from irradiated or non-irradiated WT and A12−/−SW480 colon cancer cells (CaCe) used to test the effect on tube formation in HUVECs (created with BioRender.com). B Example of tube formation by HUVECs with examples of branches, junctions, and meshes. C–E Quantified branches (C), junctions (D), and meshes (E) formed by HUVECs when exposed to CM from SW480 cells, serum-free media (SFM), or recombinant VEGF, relative to stimulation with recombinant VEGF. One-way ANOVA with correction for multiple comparisons using false discovery rate (FDR) control by Benjamini, Krieger, and Yekutieli method was applied to test for significant differences: *p < 0.05, **p < 0.01, ***p < 0.001.

    Journal: Cancer gene therapy

    Article Title: ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy.

    doi: 10.1038/s41417-023-00643-w

    Figure Lengend Snippet: Fig. 6 ADAM12 regulates the effect of colon cancer cells on neighboring endothelial cells in vitro. A Experimental setup used to obtain conditioned media (CM) from irradiated or non-irradiated WT and A12−/−SW480 colon cancer cells (CaCe) used to test the effect on tube formation in HUVECs (created with BioRender.com). B Example of tube formation by HUVECs with examples of branches, junctions, and meshes. C–E Quantified branches (C), junctions (D), and meshes (E) formed by HUVECs when exposed to CM from SW480 cells, serum-free media (SFM), or recombinant VEGF, relative to stimulation with recombinant VEGF. One-way ANOVA with correction for multiple comparisons using false discovery rate (FDR) control by Benjamini, Krieger, and Yekutieli method was applied to test for significant differences: *p < 0.05, **p < 0.01, ***p < 0.001.

    Article Snippet: Serum-free medium (SFM) was used as an NC, and 0.5 μg/ml human recombinant Cancer Gene Therapy (2023) 30:1369 – 1381 vascular endothelial growth factor (VEGF) (R&D Systems) in SFM as a positive control.

    Techniques: In Vitro, Irradiation, Recombinant, Control

    A Experimental setup used to obtain conditioned media (CM) from irradiated or non-irradiated WT and A12 −/− SW480 colon cancer cells (CaCe) used to test the effect on tube formation in HUVECs (created with BioRender.com). B Example of tube formation by HUVECs with examples of branches, junctions, and meshes. C – E Quantified branches ( C ), junctions ( D ), and meshes ( E ) formed by HUVECs when exposed to CM from SW480 cells, serum-free media (SFM), or recombinant VEGF, relative to stimulation with recombinant VEGF. One-way ANOVA with correction for multiple comparisons using false discovery rate (FDR) control by Benjamini, Krieger, and Yekutieli method was applied to test for significant differences: * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Cancer Gene Therapy

    Article Title: ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy

    doi: 10.1038/s41417-023-00643-w

    Figure Lengend Snippet: A Experimental setup used to obtain conditioned media (CM) from irradiated or non-irradiated WT and A12 −/− SW480 colon cancer cells (CaCe) used to test the effect on tube formation in HUVECs (created with BioRender.com). B Example of tube formation by HUVECs with examples of branches, junctions, and meshes. C – E Quantified branches ( C ), junctions ( D ), and meshes ( E ) formed by HUVECs when exposed to CM from SW480 cells, serum-free media (SFM), or recombinant VEGF, relative to stimulation with recombinant VEGF. One-way ANOVA with correction for multiple comparisons using false discovery rate (FDR) control by Benjamini, Krieger, and Yekutieli method was applied to test for significant differences: * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: Serum-free medium (SFM) was used as an NC, and 0.5 μg/ml human recombinant vascular endothelial growth factor (VEGF) (R&D Systems) in SFM as a positive control.

    Techniques: Irradiation, Recombinant, Control